Introduction Crohn’s disease (CD) is a chronic inflammatory condition of the gastrointestinal tract characterized by relapsing episodes of inflammation, which often leads to progressive bowel damage and impaired quality of life. Biologic therapies have become a mainstay in managing moderate-to-severe cases; however, a substantial number of patients